Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

导出原文传递

翻译打印收藏纠错

作者： Ravandi, Farhad ^[1] ; O'Brien, Susan M. ^[2] ; Cortes, Jorge E. ^[3] ; Thomas, Deborah M. ^[4] ; Garris, Rebecca ; Faderl, Stefan ; Burger, Jan A. ; Rytting, Michael E. ; Ferrajoli, Alessandra ; Wierda, William G. ; Verstovsek, Srdan ; Champlin, Richard ; Kebriaei, Partow ; McCue, Deborah A. ; Huang, Xuelin ; Jabbour, Elias ; Garcia-Manero, Guillermo ; Estrov, Zeev ; Kantarjian, Hagop M.

作者单位： Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA ^[1] Univ Texas MD Anderson Canc Ctr, Dept Cellular Therapy & Stem Cell Transplantat, Houston, TX 77030 ^[2] Univ Texas MD Anderson Canc Ctr, Dept Pharm, Houston, TX 77030 USA ^[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA ^[4]

关键词 acute lymphoblastic leukemia chemotherapy combination dasatinib Philadelphia chromosome

发布时间 2016-01-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交